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Abstract
Renal scarring after pyelonephritis is linked to long-term health risks for hypertension and chronic kidney disease. Androgen exposure increases susceptibility to, and
severity of, uropathogenic Escherichia coli (UPEC) pyelonephritis and resultant
scarring in both male and female mice, while anti-androgen therapy is protective
against severe urinary tract infection (UTI) in these models. This work employed
androgenized female C57BL/6 mice to elucidate the molecular mechanisms of postinfectious renal fibrosis and to determine how these pathways are altered by the presence of androgens. We found that elevated circulating testosterone levels primed the
kidney for fibrosis by increasing local production of TGFβ1 before the initiation of
UTI, altering the ratio of transcription factors Smad2 and Smad3 and increasing the
presence of mesenchymal stem cell (MSC)-like cells and Gli1 + activated myofibroblasts, the cells primarily responsible for deposition of scar components. Increased
production of TGFβ1 and aberrations in Smad2:Smad3 were maintained throughout
the course of infection in the presence of androgen, correlating with renal scarring
that was not observed in non-androgenized female mice. Pharmacologic inhibition of
TGFβ1 signaling blunted myofibroblast activation. We conclude that renal fibrosis
after pyelonephritis is exacerbated by the presence of androgens and involves activation of the TGFβ1 signaling cascade, leading to increases in cortical populations
of MSC-like cells and the Gli1 + activated myofibroblasts that are responsible for
scarring.
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IN T RO D U C T ION

Urinary tract infection (UTI) affects millions of people
worldwide, exerting substantial impact both economically

and on quality of life. Uropathogenic Escherichia coli
(UPEC) cause over 80% of UTIs, including acute and recurrent bladder infection (cystitis) and ascending infection
of one or both kidneys (pyelonephritis). Epidemiologically,
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UTI is primarily a disease of females; however, infant boys
and elderly men exhibit higher rates of UTI compared to females of equivalent ages (Foxman, 2002; Foxman, Barlow,
D’Arcy, Gillespie, & Sobel, 2000; Hummers-Pradier, Ohse,
Koch, Heizmann, & Kochen, 2004; Ruben et al., 1995;
Shaikh, Morone, Bost, & Farrell, 2008; Wettergren, Jodal,
& Jonasson, 1985). Furthermore, complicated UTI in males
carries increased morbidity and mortality compared to that of
females (Foxman, 2002; Lipsky, 1989). In childhood, ~7% of
febrile UTI episodes result in formation of renal scars (Shaikh
et al., 2016), which correlate with elevated risk for hypertension, chronic kidney disease, and end-stage kidney disease
later in life (Calderon-Margalit et al., 2018; Efstathiou et al.,
2003; Foxman, Klemstine, & Brown, 2003; Ki, Park, Choi,
& Foxman, 2004; Nicolle, Friesen, Harding, & Roos, 1996;
Ricardo et al., 2019).
Testosterone signaling through the androgen receptor increases susceptibility to, and severity of, experimental UPEC
pyelonephritis in both male and female mice (Olson, Hruska,
& Hunstad, 2016), while anti-androgen therapy is protective
against severe UTI in mice (Olson et al., 2017) and in women
with polycystic ovary syndrome (Gamal, Elkholi, & Nagy,
2016; Wang, Su, Liu, Chang, & Chen, 2005), a common hyperandrogenic condition. As observed in children, mice with
severe pyelonephritis develop renal fibrosis and scarring
(Olson et al., 2018). In non-infectious models of renal injury,
fibrosis is caused by excess extracellular matrix (ECM) deposition by α-smooth muscle actin (αSMA)-positive activated
myofibroblasts. Just over half of activated myofibroblasts are
derived from Gli1+ mesenchymal stem cell (MSC)-like cells
that reside in the perivascular niche (Kramann, Fleig, et al.,
2015; Kramann, Schneider, et al., 2015). The remaining activated myofibroblasts in the recently injured kidney may be
derived from several different progenitor cell types including
resident fibroblasts, epithelial cells, endothelial cells, or precursors recruited from the bone marrow (Chen et al., 2011;
Iwano et al., 2002; Ng et al., 1998; Piera-Velazquez, Li, &
Jimenez, 2011; Reich et al., 2013; Schnaper, Hayashida,
Hubchak, & Poncelet, 2003; Wu et al., 2013; Xavier et al.,
2015). However, activated myofibroblasts can lose their progenitor cell type-specific markers during transition, making
it challenging to definitively determine their cell lineage
(Humphreys, 2018).
Activated myofibroblasts are highly sensitive to TGFβ1
signaling, the production of which is known to be upregulated following experimental non-infectious renal injury
(Gentle et al., 2013; Loeffler & Wolf, 2014). Ligation of the
TGFβ1 receptor leads to phosphorylation of the transcription
factors Smad2 and Smad3, which then complex with Smad4
and translocate into the nucleus, upregulating transcription
of αSMA and ECM components such as collagens I and III
(Hill, 2009; Inman, Nicolás, & Hill, 2002). Other TGFβ superfamily members (e.g., activin A), as well as members of
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the Hedgehog signaling cascade (e.g., Gli1), can also signal
through Smad transcription factors using nonredundant receptors and pathways (Agapova, Fang, Sugatani, Seifert,
& Hruska, 2016; Kramann, 2016; Yamashita, Maeshima,
Kojima, & Nojima, 2004; Zhang, Tian, & Xing, 2016). Under
normal conditions, a renal insult subsides and the secreted
ECM is subsequently degraded by locally generated collagenases (Bauman et al., 2010; Wang et al., 2006; Zeisberg
et al., 2003), enabling productive healing and regeneration of
functional tubules in the affected area of kidney. Aberrations
in this signaling cascade, or more severe or prolonged injury,
may push fibrotic signaling beyond the point of no return,
precluding productive repair and resulting in permanent scarring (Genovese, Manresa, Leeming, Karsdal, & Boor, 2014).
We recently developed a preclinical model in which experimental pyelonephritis (even when successfully treated
with clinically relevant antibiotics) results in scar formation
in C3H mice, a strain featuring vesicoureteral reflux (Olson
et al., 2017). Here, we extended these models into non-refluxing C57BL/6 mice, which when androgenized are permissive for pyelonephritis, but without the abscess formation
seen in C3H mice (Olson et al., 2018). This system allowed
us to interrogate the molecular mechanisms of renal fibrosis,
separate from the severity of UTI per se, and to specify how
the activity of these pathways is enhanced in the presence of
androgens.
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Bacterial strains

Uropathogenic Escherichia coli (UPEC) strain UTI89, a
clinical cystitis isolate (Chen et al., 2009), was grown in
Luria-Bertani (LB; Becton Dickinson [BD]) broth statically
overnight at 37°C. Cultures were centrifuged for 10 min at
7,500g at 4°C before being resuspended in sterile phosphatebuffered saline (PBS) to a density of ~4 × 108 colony-forming units (CFU)/ml.

2.2
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Animals

All animal protocols received prior approval from the
Washington University Institutional Animal Care and Use
Committee. Experiments were conducted in C57BL/6 mice
(#000664; Jackson Laboratories) or, for immunofluorescence studies, in bigenic Gli1-tdTomato+ mice harboring
a tamoxifen-inducible Cre that enables tdTomato production from the Gli1 promoter (kind gift of B. Humphreys;
(Kramann, Schneider, et al., 2015)). For androgenization,
female mice of either strain were administered testosterone cypionate (TC; Depo-Testosterone, Pfizer) 150 mg/

   

HREHA et al.

kg IM weekly beginning at 5 weeks of age and continuing
until sacrifice. UTI was initiated by bladder inoculation
with 1–2 × 107 CFU of UPEC via catheter at 7 weeks of
age, as described previously (Hannan & Hunstad, 2016;
Hung, Dodson, & Hultgren, 2009). Experiments were
conducted similarly in Gli1-tdTomato+ mice, with the
addition of three doses of tamoxifen (0.1 mg/kg IP in
corn oil/3% ethanol; Sigma) ending 10 days before UTI
initiation.

2.3
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TGFβ1 receptor inhibition experiments

For TGFβ1 receptor inhibition experiments, mice were
treated as described above, and treated with the ALK5specific inhibitor GW788388 (Gellibert et al., 2006) (Selleck
Chemicals), 3 mg/kg IP with 6% DMSO in PBS, daily for
7 days beginning 1 day prior to UTI initiation. Mice were
sacrificed 7 dpi as described below.
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Determination of bacterial loads

At the indicated time points, mice were terminally anesthetized with inhaled isoflurane (Patterson Veterinary, Greeley,
CO) and perfused with 4°C PBS via the left ventricle.
Bladders and kidneys were aseptically removed and homogenized in 4°C PBS; tissue homogenates were serially diluted
and plated on LB agar.
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Serum analysis

Blood was collected by submandibular puncture, or by cardiac puncture for collections at the time of sacrifice, into
BD Microtainer serum separator tubes and centrifuged at
10,000g. Serum testosterone and estradiol measurements
were performed by enzyme immunoassay at the Ligand
Assay and Analysis Core, University of Virginia Center for
Research in Reproduction.
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Quantitative RT-PCR

At various time points, mRNA was extracted from flash-frozen kidneys with RNA Stat-60 (Amsbio), according to manufacturer's instructions. 1 µg mRNA was converted to cDNA
with the iScript cDNA Synthesis Kit (Bio-Rad) according to
the manufacturer's instructions. Roughly 20 ng of cDNA was
run in triplicate with SsoAdvanced Universal SYBR Green
Supermix (Bio-Rad) containing 350 nM primers. Thermal
cycling was performed using an Applied Biosystems Fast
7500 RT-PCR system with the following protocol: 95°C,
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3 min; 40 × (95°C, 10 s; 60°C, 30 s). Primers used in this
study are provided in Table S1.
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Tissue preparation and histology

Mice were euthanized as described above, and excised kidneys were fixed in 4% paraformaldehyde in PBS at 4°C for
1 hr, then incubated overnight in 30% sucrose in PBS at 4°C
before embedding into OCT (Fisher Scientific). Embedded
tissues were cryosectioned into 5- to 8-µm sections and
mounted on Superfrost Plus slides (Fisher Scientific).
Gomori trichrome staining was performed with the Gomori
Trichrome Stain Kit (Richard-Allan Scientific) according to
the manufacturer's instructions.
For immunohistochemistry, sections were washed with
Tris-buffered saline (TBS; 50 mM Tris, 150 mM NaCl,
pH 7.6), incubated with 3% H2O2 in methanol, washed
with TBS, and blocked with 10% fetal bovine serum
(FBS; Gibco, Dublin, Ireland) in TBS. Sections were then
stained for collagen I (1:250, SouthernBiotech #131001, RRID:AB_2753206), washed with TBS, and probed
with 1:250 biotinylated anti-goat IgG (Invitrogen #31730,
RRID:AB_228368), then washed with TBS and probed
again with 1:250 streptavidin-HRP (ThermoFisher Scientific
#N504). After washing, sections were developed with DAB
(Vector Laboratories #SK-4100), according to the manufacturer's instructions. Sections were washed again, and dyed
with Gill No. 2 Hematoxylin (Sigma) before dehydration and
mounting. For analysis, 10 random images of each section
were taken at 10× magnification, and quantified using the
IHC profiler plugin for ImageJ (National Institutes of Health;
Bethesda, MD (Varghese, Bukhari, Malhotra, & De, 2014)).
Representative IHC images are presented in Figure S6.
For immunofluorescence microscopy, sections were
washed with PBS, blocked with 10% FBS in PBS, and stained
with primary antibodies against CD140b (APB5)-APC
(1:200, eBioscience #14-1402, RRID:AB_467493), αSMA
(1A4/asm-1)-PerCP (1:150, Novus Biologicals #NBP234522PCP), aquaporin 2 (E2)-AlexaFluor 647 (1:200, Santa
Cruz Biotechnology #sc-515770, RRID:AB_2810957),
aquaporin 1 (B-11)-AlexaFluor 647 (1:200, Santa Cruz
Biotechnology #sc-25287, RRID:AB_626694), TammHorsfall protein (774056) (THP, uromodulin; 1:200,
ThermoFisher #MA5-24374, RRID:AB_2606307), calbindin D28k (D-4)-AlexaFluor 647 (1:200, Santa Cruz
Biotechnology
#sc-365360,
RRID:AB_10841576),
or TGFβ1 (3C11)-AlexaFluor 594 (1:200, Santa Cruz
Biotechnology #sc-130348, RRID:AB_1567351). Sections
were washed with PBS and probed when necessary with a
goat anti-rabbit AlexaFluor 488-conjugated secondary antibody (1:300, Jackson ImmunoResearch #111-095-144,
RRID:AB_2337978). Sections were then stained with
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1:5,000 4′,6-diamidino-2-phenylindole (DAPI) and mounted
with ProLong Gold (both from Life Technologies). Images
were captured digitally using a Zeiss LSM 880 Airyscan confocal microscope.
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Flow cytometry

Kidneys were harvested as described above and manually
homogenized into 4°C RPMI (Gibco), then treated with
RBC lysis buffer (155 mM NH4Cl, 10 mM KHCO3) at room
temperature to ensure lysis of any RBCs remaining after perfusion. After washing, cells were resuspended in 4°C PBS
and stained with Live/Dead Fixable Yellow (ThermoFisher
Scientific). After staining and washing, cells were resuspended in 4°C FACS buffer (10% FBS, 1% w/v sodium
azide in PBS) and treated with Fc Block (BD Biosciences)
on ice, then stained with labeled antibodies against the following extracellular antigens: E-cadherin (CD324)-PE-Cy7
(1:200, Biolegend #147309, RRID:AB_2564187), nestin
(Rat-401)-FITC (1:20, Santa Cruz Biotechnology #sc-33677,
RRID:AB_627995), CD140b (APB5)-APC (1:20, Biolegend
#136008, RRID:AB_2268091), and CD45 (30-F11)-BV510
(1:200, BD Biosciences #563891, RRID:AB_2734134).
Cells were washed again, fixed in 4% paraformaldehyde in
PBS, and permeabilized on ice with Perm/Wash buffer (10%
FBS, 1% w/v sodium azide, 1.3 mM saponin in PBS, pH 7.4–
7.6). The cells were then stained with the following labeled
intracellular antibodies: Gli1 (C-1)-PE (1:25, Santa Cruz
Biotechnology #sc-515751), αSMA (1A4/asm-1)-PerCP
(1:10, Novus Biologicals #NBP2-34522PCP), and TGFβ1
(9016)-AlexaFluor 700 (1:50, R&D Systems #IC240N,
RRID:AB_884506). After staining, cells were washed, resuspended in FACS buffer, and subjected to flow cytometry
on an LSR II Fortessa instrument (BD Biosciences); results
were analyzed using FlowJo software (Tree Star Inc.). A representation of the gating scheme used for analysis is provided
in Figure S7.
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Immunoblotting

Kidneys were harvested as described above, flash frozen in
liquid nitrogen, and stored at −80°C until use. They were homogenized in RIPA buffer (50 mM Tris-HCl, 150 mM NaCl,
1% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate, pH
7.4) containing PhosSTOP phosphatase inhibitor and cOmplete Mini protease inhibitor (both from Roche). Lysates
were cleared by centrifugation (2 × 5 min at max speed), and
total protein concentration was determined by bicinchoninic
acid assay (Invitrogen). 80 µg protein per lane was loaded
into SDS-PAGE gels and transferred to PVDF membranes.
Membranes were blocked with 5% milk (Carnation) in PBS
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with 0.05% Tween-20 (PBST) and probed with primary antibodies for Smad2/3 (C-8) (1:500, Santa Cruz Biotechnology
#sc-133098, RRID::AB_2193048) and CoxIV (1:20,000,
Cell Signaling Technologies #4844, RRID:AB_2085427)
overnight at 4°C. Membranes were then washed with
PBST and probed with respective horseradish peroxidaseconjugated secondary antibodies (GE Healthcare #NA931,
RRID:AB_772210 and #NA934, RRID:AB_772206) at
1:2000 in blocking buffer for 1 hr at room temperature.
Membranes were washed again with PBST and developed
with Clarity Western ECL Kit (Bio-Rad). Western blots were
quantified using the Analyze Gels plugin on ImageJ.
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Statistical analysis

Organ bacterial loads and IHC quantification were compared
using the nonparametric Mann–Whitney U test. All other
comparisons were made using an unpaired t test. p values
<.05 were considered significant.

3
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RESULTS

3.1 | Androgens augment TGFβ1
production in the kidney
To investigate the effect of androgens on renal fibrosis following pyelonephritis, female C57BL/6 mice were treated weekly
with 150 mg/kg of testosterone cypionate (TC) or vehicle
beginning 2 weeks before UPEC inoculation. Mice treated
with TC had significantly higher levels of serum testosterone
compared to vehicle-treated mice, accompanied by mild but
detectable increases in serum estradiol levels, presumably
via aromatization (Figure S1). Consistent with our prior data
showing more severe UTI outcomes in androgenized hosts,
TC-treated mice harbored significantly higher bladder and
kidney bacterial loads at later time points (14 and 28 dpi),
with a higher proportion of TC-treated mice exhibiting hightiter pyelonephritis (>104 CFU; Figure S2). Elevation of circulating androgens increased both expression and production
of TGFβ1 globally in the kidney. Transcript levels of Tgfb1 in
the whole kidney were slightly higher at the time of infection
and were significantly higher in TC-treated mice 1-day postinfection (Figure 1a). Flow cytometry analysis determined
that at baseline (prior to initiation of UTI), increased TGFβ1
protein expression in TC-treated mice was observed only in
non-hematopoietic (CD45−) cell populations comprising the
renal parenchyma. Among these CD45− subsets, TGFβ1
production by renal epithelial cells (E-cadherin+, CD45−)
peaked early (1 dpi) in response to UPEC infection in both
vehicle- and TC-treated mice. TGFβ1 protein production by
epithelial cells in the kidneys of TC-treated mice was also

HREHA et al.
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F I G U R E 1 TGFβ1 levels are upregulated in the kidneys of TC-treated mice. Female C57BL/6 mice were injected weekly with 150 mg/kg
testosterone cypionate (TC) or vehicle starting at 5 weeks of age before transurethral inoculation of 107 CFU of UPEC 2 weeks later. (a) Relative
mRNA transcript levels of Tgfb1 (normalized to Gapdh) in vehicle-treated (open bars) or TC-treated (gray bars) mice at various time points before
and after UPEC inoculation; n = 4–8 mice per group, mean transcript level in vehicle-treated mice set to 1 arbitrary unit at each time point. Relative
mean fluorescence intensity (MFI) of TGFβ1 in (b) epithelial and (c) non-epithelial cells, shown as a proportion of the MFI of live, CD45− cells,
was determined by flow cytometry of whole kidney in vehicle-treated (open triangles) or TC-treated (filled triangles) mice; n = 4–12 mice per
group. *p < .05, **p < .01, ***p < .001

increased compared to those of vehicle-treated mice 1 and
7 dpi (Figure 1b). Immunofluorescence microscopy revealed
TGFβ1 production throughout the nephron but primarily in
the thick ascending loop and distal tubule in both vehicle and
TC-treated mice, both before and 1 day post infection, with
no significant TGFβ1 production in the medulla (Figure 2,
Figure S3). Meanwhile, TGFβ1 production by non-epithelial
cell subsets (CD45−, E-cadherin−; comprising endothelial
cells, vascular smooth muscle cells, podocytes, mesangial
cells, fibroblasts, and activated myofibroblasts) was consistently higher in TC-treated mice than in vehicle-treated mice
across all time points (0–28 dpi), steadily increasing over
time only in TC-treated mice (Figure 1c).

3.2 | Increased early TGFβ1 perturbs
levels of downstream fibrotic signaling factors
In other global kidney injury models (e.g., unilateral ureteral obstruction [UUO]), increased TGFβ1 production in
the kidney alters the ratio of transcription factors Smad2
and Smad3, favoring activation of fibrosis programs (Kim
et al., 2005). In addition, testosterone treatment of cultured
ovarian epithelial cells was shown to suppress Smad3 production (Kollara, Shathasivam, Park, Ringuette, & Brown,
2020). At the time points noted above after UPEC infection
of C57BL/6 mice, we performed quantitative immunoblots
on whole kidney homogenates for total Smad2 and Smad3
(Figure 3a). Kidneys of TC-treated mice exhibited a higher
Smad2:Smad3 ratio than vehicle-treated mice, beginning before the onset of UTI and continuing throughout the course
of infection (Figure 3b). Of note, we could not reliably detect
phospho-Smad2 and phospho-Smad3 in these homogenates

despite multiple approaches (see Discussion). By qPCR analysis of whole-kidney RNA, Smad2 expression in TC-treated
mice was statistically equivalent to that in vehicle-treated
mice across the course of infection (Figure 3c), while Smad3
expression was significantly suppressed in TC-treated mice
at 7 dpi, recovering by 28 dpi (Figure 3d). These data indicate
that androgen exposure facilitates Smad3 suppression in the
infected kidney, thereby promoting fibrosis after infectious
injury.

3.3 | Androgen exposure augments TGFβ1driven myofibroblast activation
TGFβ1 signaling in other renal injury models recruits
Gli1+ MSC-like progenitor cells from the perivascular space
and promotes the conversion of these cells and Gli1− kidney-resident MSC-like cells into activated myofibroblasts
capable of depositing extracellular matrix components, including collagens (Asada et al., 2011; Kramann, Schneider,
et al., 2015; Wan et al., 2012; Wu et al., 2013). We used flow
cytometry to interrogate the effect of androgen exposure on
the populations of kidney-resident MSC-like cells (CD45−,
E-cadherin−, PDGFRβ+, Gli1−; consisting of fibroblasts,
mesangial cells, and pericytes (Boor, Ostendorf, & Floege,
2014; Klinkhammer, Floege, & Boor, 2018; Wu et al.,
2013)) and activated myofibroblasts (CD45−, E-cadherin−,
PDGFRβ+, Gli1+, αSMA+, and Nestin+ (Humphreys, 2018;
Kramann, Schneider, et al., 2015)) in the kidney before and
throughout UPEC pyelonephritis. Prior to the onset of UTI,
the kidneys of TC-treated mice harbored slightly more MSClike cells (Figure 4a) and significantly more activated myofibroblasts (Figure 4b) than in vehicle-treated mice. Moreover,
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F I G U R E 2 TGFβ1 is produced in selected tubular segments in both vehicle and TC-treated mice. Immunofluorescence imaging of 8-µm
sections of fixed, frozen kidneys shows that the TGFβ1 (red in all images) is primarily produced in the distal tubule (green, calbindin D28k)
and thick ascending loop (green, Tamm-Horsfall protein [THP]), while TGFβ1 did not colocalize with the proximal tubule (green, aquaporin-1
[AQP1]), or the collecting duct (green, aquaporin-2 [AQP2]) in vehicle- or TC-treated mice at the time of UPEC inoculation and 1 dpi. Scale bar
represents 20 µm

the relative amount of TGFβ1 produced at baseline in both
the MSC-like cells (Figure 4c) and activated myofibroblasts
(Figure 4d) was significantly higher in TC-treated mice. This
augmented recruitment of MSC-like cells and activation of
myofibroblasts, in conjunction with their increased TGFβ1
expression, suggests that androgen exposure “primes” these
cell populations within the kidney for fibrotic signaling, even
before renal injury occurs.
Over a time course following UPEC inoculation, MSClike cells were significantly more populous in androgenized

mice only at 7 dpi (Figure 5a). Meanwhile, the population
of activated myofibroblasts was significantly elevated in
TC-treated mice beginning 7 dpi (p = .0096 vs. TC-treated
mice at 1 dpi), while in vehicle-treated mice, this population
was elevated only much later (28 dpi; p = .0187 vs. vehicle-treated mice at 14 dpi; Figure 5b). Of note, in uninfected
mice treated with vehicle or TC and allowed to grow to ages
equal to those 14 or 28 dpi (9- and 11-week old, respectively),
populations of MSC-like cells resembled those in comparable
UPEC-infected mice (Figure S4a). In contrast, the activated
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|

7 of 14

F I G U R E 3 TC treatment alters the Smad2:Smad3 ratio throughout the course of infection. The ratio of Smad2 and Smad3 was determined
by immunoblot (as exemplified with five individual vehicle- and TC-treated mice 14 dpi) in panel (a) and quantified in (b), at the time of UPEC
inoculation and at 1, 7, 14 and 28 dpi in whole-kidney homogenates from vehicle-treated mice (open triangles) or TC-treated mice (filled triangles);
n = 7–10 mice per group. The relative mRNA expression of (c) Smad2 and (d) Smad3 in whole kidney (normalized to Gapdh) was determined
at the above time points in both vehicle-treated (open bars) and TC-treated (gray bars) mice; n = 4–8 mice per group. *p < .05, **p < .01,
***p < .001

myofibroblast population was not significantly different between uninfected vehicle- and TC-treated mice (Figure S4b),
indicating that the infectious injury was specifically required
to induce myofibroblast activation.
Over time following UPEC infection, the amount of
TGFβ1 produced by MSC-like cells and activated myofibroblasts (on a per-cell basis) increased in both TC- and
vehicle-treated mice (Figure 5c and d), similar to the time
course of TGFβ1 transcription and production reported in
other renal injury models (Kilari, Yang, Sharma, McCall, &
Misra, 2018; Popova et al., 2010; Wu et al., 2013). In MSClike cells, TGFβ1 production was higher in TC-treated mice
than in vehicle-treated mice only at 28 dpi (Figure 5c); this
also occurred in uninfected TC-treated mice of similar age
(Figure S4c). TGFβ1 production in MSC-like cells rose
in TC-treated mice over time (28 dpi vs. 14 dpi, p = .026;
Figure 5c). Similarly, per-cell TGFβ1 production by activated
myofibroblasts in TC-treated mice was significantly higher
than in vehicle-treated mice only at 14 dpi (Figure 5d), when
the activated myofibroblast population was also comparatively greatest (Figure 5b). Immunofluorescence microscopy
indicated that these activated myofibroblasts are the predominant cellular sources of TGFβ1 within the kidney 14 dpi
(Figure S5). Although TC treatment of uninfected mice
did significantly increase TGFβ1 production by activated

myofibroblasts (Figure S4d), this effect of androgenization
was amplified in UPEC-infected mice (p = .026 vs. uninfected
at 14 dpi; p = .039 at 28 dpi; Figure 5d). Taken together, these
data indicate that the chief effect of androgen exposure is to
enhance TGFβ1 production by multiple cell types within the
kidney, leading to accelerated activation and proliferation of
myofibroblasts upon subsequent UPEC-induced injury.

3.4 | Androgen-enhanced myofibroblast
activation correlates with scar formation
Prior work indicates that local myofibroblast activation
drives fibrotic scarring in non-infectious, global renal injury models (Humphreys et al., 2010; Kramann, Schneider,
et al., 2015; Picard, Baum, Vogetseder, Kaissling, & Le
Hir, 2008; Sato & Yanagita, 2017). In comparison, our
pyelonephritis model features regional injury and scarring that is comparatively limited in scope; as a result,
analysis of our whole-kidney homogenates did not reveal
increased Col1A1 (collagen I) and Acta2 (α-smooth muscle actin) transcription in TC-treated mice (Figure 6a and
b). Quantified IHC staining indicated an increase in collagen I deposition in the kidneys of TC-treated mice at
14 dpi (Figure 6c), while collagen I staining had equalized
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To further test whether androgen-enhanced TGFβ1 was
driving myofibroblast activation and scarring following
UPEC pyelonephritis, we administered a specific TGFβ1
receptor antagonist (GW788388; (Gellibert et al., 2006;
Lagares et al., 2010; McMillin et al., 2019; Petersen et al.,
2008)) to TC-treated mice for 7 days, beginning the day
prior to UPEC inoculation. As seen in our initial experiments (Figure 1), androgen treatment (vs. vehicle) increased
TGFβ1 production by CD45− cell populations 7 dpi; as
expected, this increase was unaltered by GW788388 treatment (Figure 9a and b). Similarly, MSC-like cell numbers
were increased by androgen treatment (vs. vehicle) and
not further changed by GW788388 treatment (Figure 9c).
However, GW788388 treatment did significantly diminish
the activated myofibroblast population in androgenized
kidneys (Figure 9d), consistent with a model in which
TGFβ1 mediates androgen-enhanced renal scarring following UPEC infection.

4

F I G U R E 4 Increased TGFβ1 signaling primes TC-treated mice
for fibrosis by increasing myofibroblast activation. The populations
of (a) MSC-like cells and (b) activated myofibroblasts as a percentage
of the total live, CD45− population at the time of infection were
determined by flow cytometry in vehicle-treated (open triangles) or
TC-treated mice (filled triangles). The MFI of TGFβ1 produced by
(c) MSC-like cells and (d) activated myofibroblasts as a proportion of
the MFI of live, CD45− cells of vehicle- or TC-treated mice was also
determined by flow cytometry of whole kidney at the time of infection.
n = 5 mice per group; ***p < .001

between groups by 28 dpi. Furthermore, TC-treated mice
developed regions of focal scarring visible (by Gomori
trichrome staining) in the renal cortex by 14 dpi and persisting through 28 dpi; such regions were not identified in
vehicle-treated mice (Figure 6d). We performed analogous
infections in TC-treated Gli1-tdTomato+ mice, and the resulting scars contained streaks of activated myofibroblasts,
which stained positively for αSMA, Gli1 (via the Tomato
fluorophore), and PDGFRβ, and were surrounded by areas
of dense collagen deposition (Figure 7). Activated myofibroblasts are normally present (in the absence of injury)
in the renal medulla and near the vasculature (Kramann,
Schneider, et al., 2015); in our infection model, these cells
were visible in the medulla in both TC- and vehicle-treated
mice (Figure 8a and c). However, they were found in cortical locations only in TC-treated mice (Figure 8b and d),
consistent with the localization of renal scars in these mice.

|

DISCUSSION

In this work, we demonstrate that renal fibrosis after experimental UPEC pyelonephritis is driven by TGFβ1 and
enhanced by androgens. Specifically, androgen exposure
augments the production of fibrotic signaling factors (including TGFβ1) globally in the kidney, and alters the relative expression of the downstream transcription factors Smad2 and
Smad3. In other models of renal fibrosis following non-infectious insult, MSC-like cell populations residing in the kidney
and recruited from circulating precursors become activated
myofibroblasts after local exposure to TGFβ1, subsequently
depositing extracellular matrix components around the injured area that ultimately form a scar (Humphreys, 2018;
Meng, Nikolic-Paterson, & Lan, 2016). Here, we show that
an analogous process underlies scarring after UPEC pyelonephritis, and we delineate the cellular and molecular mechanisms that are accelerated in the presence of androgens.
We previously showed that androgen exposure was linked
to high-titer pyelonephritis and significant renal scarring in
C3H/HeN mice (Olson et al., 2016), which feature vesicoureteral reflux as a risk factor for upper-tract UTI. In the present work, we utilized non-refluxing C57BL/6 mice, which
develop pyelonephritis of more modest severity after UPEC
inoculation of the bladder. As we reported in the C3H background (Olson et al., 2016, 2018), androgen exposure was
here found also to increase the rate of high-titer pyelonephritis in C57BL/6 mice. Compared with the extensive scars
formed in UPEC-infected C3H mice (Olson et al., 2017), the
BL/6 background enabled us to model of more limited renal
scar formation, without overwhelming inflammation, and offers many more readily available genetic tools to enable future investigation.
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F I G U R E 5 Androgen exposure
influences fibroblast and myofibroblast
activation and TGFβ1 production
throughout the course of infection. The
population of (a) MSC-like cells and (b)
activated myofibroblasts as a percentage of
live, CD45− cells was determined by flow
cytometry of whole kidney in vehicletreated (open triangles) or TC-treated (filled
triangles) mice at 1, 7, 14, and 28 dpi.
The relative MFI of TGFβ1 production
compared to live, CD45− cells in (c) MSClike cells and (d) activated myofibroblasts at
the same time points was also determined by
flow cytometry in vehicle- and TC-treated
mice. n = 4–12 mice per group; *p < .05,
**p < .01

F I G U R E 6 Increased myofibroblast
activation in TC-treated mice is associated
with early and persistent inflammation and
scarring in the renal cortex. Relative mRNA
expression of (a) Collagen I (Col1A1) and
(b) αSMA (Acta2) compared to GAPDH in
vehicle-treated (open bars) and TC-treated
(gray bars) at the time of UPEC inoculation
and 1, 7, 14, and 28 dpi. n = 6–8 mice
per group. (c) Collagen I deposition was
quantified after immunohistochemical
staining of 8-µm sections of fixed, frozen
kidneys of vehicle- and TC-treated mice at
14 and 28 dpi. n = 102–136 random images
from 12 to 15 sections from five mice per
group. (d) 8-µm sections of fixed, frozen
kidneys of vehicle- or TC-treated mice
14 and 28 dpi were stained with Gomori
trichrome, highlighting collagen in blue.
**p < .01; scale bar represents 50 µm

Our qPCR and flow cytometric analyses showed that global
TGFβ1 levels in the kidney were increased in androgenized

mice even in the absence of injury. Androgenized mice exhibited corresponding increases in the population of MSC-like
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F I G U R E 7 Activated myofibroblasts are localized to regions of scarring in TC-treated mice. Immunofluorescence staining of 8-µm sections
of fixed, frozen kidneys from TC-treated Gli1-tdTomato mice 28 dpi show that activated myofibroblasts stain positively for αSMA+ (violet), Gli1+
(red), and PDGFRβ+ (green). Gomori trichrome staining of the adjacent section demonstrates that the activated myofibroblasts reside in areas of
high collagen deposition and inflammation. Scale bar represents 50 µm

cells and activated myofibroblasts residing in the kidney before infectious insult. These data indicate that androgen exposure itself promotes an environment that is primed for an
enhanced fibrotic response should an injury occur. Indeed,
male sex is reported as a risk factor for poor renal outcome
(Eriksen & Ingebretsen, 2006; Evans et al., 2005; Iseki,
Iseki, Ikemiya, & Fukiyama, 1996). Epidemiologic data
from the United States, Europe and Japan show that kidney
disease progresses faster in men than in women, resulting
in men having a 60% greater incidence of end-stage kidney
disease (Centers for Disease Control & Prevention, 2019;
Gretz, Zeier, Geberth, Strauch, & Ritz, 1989; Neugarten &
Golestaneh, 2013).
Once UPEC infection began, the TGFβ1 signaling cascade was persistently more active in the androgenized host.
Tgfb1 transcription was increased in TC-treated mice early
in infection, with elevated TGFβ1 production observed in
TC-treated mice was most evident in epithelial cells, predominantly in the distal nephron, earlier in infection (up to
7 dpi) and then in non-epithelial (CD45−, E-cadherin−) cell
types later in infection (7–28 dpi). This sequence is logical, as renal epithelial surfaces are likely contacted earliest

by UPEC during ascending infection (Li et al., 2017; Olson
et al., 2018). Thus, epithelial TGFβ1 signaling is likely the
initiator of the fibrotic response to infection; in other models,
TGFβ1 signaling from epithelial cells alone is sufficient to
drive a fibrotic response to injury (Gentle et al., 2013; Olson
et al., 2018).
The Smad2:Smad3 ratio was also consistently higher in
the kidneys of TC-treated mice than in vehicle-treated mice
throughout the course of infection, apparently driven primarily by suppression of Smad3. Although phosphorylation of
Smad2 and Smad3 is required for these transcription factors
to translocate to the nucleus and promote transcription of
ECM components (Meng et al., 2016), we were unable to
successfully quantify phospho-Smad2/3 in the whole kidney
despite several approaches. In contrast to other experimental renal injuries that are global (e.g., UUO), experimental
pyelonephritis is a localized process, affecting only a limited portion of the kidney (Olson et al., 2016, 2017, 2018);
as outlined above, this is particularly true in the BL/6 host
and thereby limits our ability to discern changes in such analytes through analysis of whole-kidney homogenates. Further
work will need to be done to demonstrate phospho-Smad2/3
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F I G U R E 8 Activated myofibroblasts
are localized to the renal cortex only in
TC-treated mice. Immunofluorescence
imaging of 8-µm sections of fixed, frozen
kidneys from vehicle- or TC-treated Gli1tdTomato mice 28 dpi shows that activated
myofibroblasts (αSMA+ (violet), Gli1+
(red), and PDGFRβ+ (green)) and MSClike cells (PDGFRβ+ alone) are identified
in the medulla in mice receiving either
TC (a) or vehicle (c), whereas activated
myofibroblasts are observed in the renal
cortex only in TC-treated mice (b), and
not in vehicle-treated mice (d). Scale bar
represents 50 µm

a

b

c

d
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F I G U R E 9 TGFβR1 inhibition
limits androgen-enhanced myofibroblast
activation. TGFβ1 production (MFI
compared to live, CD45− cells) was
measured 7 dpi in mice receiving vehicle/
vehicle (open triangles), TC/vehicle
(filled triangles), or TC/GW788388
(filled diamonds) in (a) epithelial and
non-epithelial cells or (b) MSC-like cells
and activated myofibroblasts. The relative
population of (c) MSC-like cells and (d)
activated myofibroblasts as a percentage
of live, CD45− cells was also determined
in these groups. n = 5–10 mice per group;
*p < .05, **p < .01, ***p < .001

alterations at the cellular level in scarred areas, rather than
globally throughout the kidney. However, an altered total
Smad2:Smad3 ratio was also shown in vitro to be a hallmark

of fibrotic signaling (Kim et al., 2005), lending support to our
conclusion that these transcription factors are key mediators
of the post-pyelonephritic scarring program.
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Ultimately, TGFβ1 signaling in the infected kidney promotes the recruitment of precursors and the activation of myofibroblasts following the initiation of UTI. These αSMA+,
Gli1+, PDGFRβ + cells are visible in the post-pyelonephritic scar as it forms and matures, and they become the
predominant producers of TGFβ1 during resolving infection.
Activated myofibroblasts were observed in the medulla independent of androgen exposure, while myofibroblasts within
collagen-rich cortical scars were observed only in the androgenized host. Global collagen I deposition (by IHC) was
enhanced in TC-treated mice at 14 dpi, but matched in vehicle-treated mice by 28 dpi, indicating that the acceleration of
myofibroblast activation in the androgenized host mediated
a pro-scarring response earlier in the course of infection.
Moreover, administration of a TGFβ receptor antagonist did
not alter global TGFβ1 production in the kidney early in infection, but did result in reduction of the activated myofibroblast population in the injured, androgenized (and therefore
scar-susceptible) host. Along these lines, a detailed understanding of the molecular and cellular basis of post-infectious
scar formation, as well as hormonal and other influences on
this injury response, may illuminate specific interventions to
mitigate scarring after infection, promote functional parenchymal healing, and reduce long-term complications.
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Circulating androgens prime the kidney for fibrosis upon infectious injury (Escherichia coli pyelonephritis) by enhancing local
TGFβ1 production and myofibroblast activation.

